Influence of hepatic cirrhosis and end-stage renal disease on pharmacokinetics and pharmacodynamics of furosemide-Reference-Cited by-同舟云学术

Influence of hepatic cirrhosis and end-stage renal disease on pharmacokinetics and pharmacodynamics of furosemide

Published:1981-06 Issue:1 Volume:20 Page:27-33
ISSN:0031-6970
Container-title:European Journal of Clinical Pharmacology
language:en
Short-container-title:Eur J Clin Pharmacol

Author:

Keller E.,Hoppe-Seyler G.,Mumm R.,Schollmeyer P.

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Pharmacology,General Medicine

Link

http://link.springer.com/content/pdf/10.1007/BF00554663.pdf

Reference24 articles.

1. Alexander WA, Levine DF, Branch RA, Hartog M (1977) Urinary sodium/potassium ratio and response to diuretics in resistant oedema. Postgrad Med J 53: 117–121

2. Andreasen F, Jakobsen P (1974) Determination of furosemide in blood plasma and its binding to proteins in normal plasma from patients with acute renal failure. Acta Pharmacol Toxicol 35: 49–57

3. Andreasen F, Mikkelsen E (1977) Distribution, elimination and effects of furosemide in normal subjects and in patients with heart failure. Eur J Pharmacol 12: 15–22

4. Beermann B, Dalen E, Lindström B (1977) Elimination of furosemide in healthy subjects and in those with renal failure. Clin Pharmacol Ther 22: 70–78

5. Benet L (1979) Pharmacokinetics, pharmacodynamics of furosemide in man: a review. J Pharmacokinet Biopharm 7: 1–27

Cited by 78 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effect of probenecid on blood levels and renal elimination of furosemide and endogenous compounds in rats: Discovery of putative organic anion transporter biomarkers;Biochemical Pharmacology;2023-12

2. Pharmacokinetics and Pharmacodynamics of Drugs in Liver Disease;Peri-operative Anesthetic Management in Liver Transplantation;2023

3. Contribution of Uptake and Efflux Transporters to Oral Pharmacokinetics of Furosemide;ACS Omega;2020-12-15

4. Safe use of medication in patients with cirrhosis: pharmacokinetic and pharmacodynamic considerations;Expert Opinion on Drug Metabolism & Toxicology;2019-12-11

5. Development of a Whole-Body Physiologically Based Pharmacokinetic Approach to Assess the Pharmacokinetics of Drugs in Elderly Individuals;Clinical Pharmacokinetics;2016-06-28